ACE and acute kidney injury: Other causes were intercurrent infections that probably led to SGLT2i suspension by clinicians as commonly done with other medications that increase the risk of AKI in infectious settings (e.g., ACE inhibitors, ARBs, and diuretics), even though we were not able to provide reliable data about resumption of treatment.